XML 71 R127.htm IDEA: XBRL DOCUMENT v3.20.1
Segments of Business - Schedule Of Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2018
Revenues                      
Revenues $ 58,535 $ 59,172 $ 57,616 $ 55,728 $ 52,429 $ 56,208 $ 53,075 $ 52,607 $ 231,051 $ 214,319 $ 208,357
Operating profit                      
Operating income                 2,410 1,568 1,208
Corporate Expenses, Net                 (1,017) (694) (564)
Loss on Debt Extinguishment                 0 0 (122)
Interest Expense                 (249) (264) (283)
Income from Continuing Operations Before Income Taxes                 1,144 610 239
Depreciation and amortization                      
Total                 922 949 951
Expenditures for long-lived assets                      
Total                 362 426 405
United States                      
Revenues                      
Revenues                 192,709 176,296 169,943
Foreign                      
Revenues                      
Revenues                 38,342 38,023 38,414
Operating Segments                      
Revenues                      
Revenues                 231,051 214,319 208,357
Corporate                      
Depreciation and amortization                      
Total                 136 122 111
Expenditures for long-lived assets                      
Total                 76 75 99
U.S. Pharmaceutical and Specialty Solutions | Operating Segments                      
Revenues                      
Revenues                 183,341 167,763 162,587
Operating profit                      
Operating income                 2,767 2,697 2,535
Depreciation and amortization                      
Total                 228 238 210
Expenditures for long-lived assets                      
Total                 94 88 126
European Pharmaceutical Solutions | Operating Segments                      
Revenues                      
Revenues                 27,390 27,242 27,320
Operating profit                      
Operating income                 (261) (1,978) (1,681)
Depreciation and amortization                      
Total                 235 257 296
Expenditures for long-lived assets                      
Total                 95 85 104
Medical-Surgical Solutions | Operating Segments                      
Revenues                      
Revenues                 8,305 7,618 6,611
Operating profit                      
Operating income                 499 455 461
Depreciation and amortization                      
Total                 136 118 97
Expenditures for long-lived assets                      
Total                 36 110 34
Other | Operating Segments                      
Revenues                      
Revenues                 12,015 11,696 11,839
Operating profit                      
Operating income                 (595) 394 (107)
Depreciation and amortization                      
Total                 187 214 237
Expenditures for long-lived assets                      
Total                 $ 61 $ 68 $ 42